Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-04-19
2010-06-01
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S011400, C514S015800, C530S300000, C530S317000, C530S328000
Reexamination Certificate
active
07727956
ABSTRACT:
Nonadepsipeptides and methods for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases are described.
REFERENCES:
patent: 4754018 (1988-06-01), Tymiak et al.
patent: 6380156 (2002-04-01), Rinehart et al.
patent: 7056942 (2006-06-01), Hildesheim et al.
patent: 7368424 (2008-05-01), Von Nussbaum et al.
patent: 7531507 (2009-05-01), Von Nussbaum et al.
patent: 2005/0075281 (2005-04-01), Von Nussbaum et al.
patent: 2005/0272646 (2005-12-01), Koteva et al.
patent: 2006/0264358 (2006-11-01), Von Nussbaum et al.
patent: 2008/0051424 (2008-02-01), Von Nussbaum et al.
patent: 2008/0058251 (2008-03-01), Von Nussbaum et al.
patent: 2008/0058253 (2008-03-01), Von Nussbaum et al.
patent: 2008/0070884 (2008-03-01), Von Nussbaum et al.
patent: 2009/0105119 (2009-04-01), Von Nussbaum et al.
patent: 196042 (1986-10-01), None
patent: 01132600 (1989-05-01), None
patent: WO-01/05814 (2001-01-01), None
patent: WO-2004/099239 (2004-11-01), None
patent: WO-2006/048156 (2006-05-01), None
Introduction to Cancer from Merck manual, p. 1. Accessed Mar. 5, 2008.
Clinical Aspects of Cancer from Merck manual, pp. 1-4. Accessed Mar. 5, 2008.
Auerbach R, Akhtar N, Lewis RL, Shinners BL, “Angiogenesis assays: PRoblems and pitfalls,” Cancer and Metastasis Reviews, 2000, 19: 167-172.
Gura T, “Systems for Identifying New Drugs are Often Faulty,” Science, 1997, 278(7): 1041-1042.
Jain RK, “Barriers to Drug Delivery in Solid Tumors,” Scientific American, Jul. 1994, 58-65.
Types of disorders from Merck manual, pp. 1-26. Accessed Jul. 29, 2009.
Types of diseases from Merck manual, pp. 1-27. Accessed Jul. 29, 2009.
Dementia from Merck manual, pp. 1-17. Accessed Jul. 29, 2009.
Mattson MP, “Pathways towards and away from Alzheimer's disease,” Nature, Aug. 2004, 430: 631-639.
Baquero, J. Antimicrob. Chemother. (1997 Suppl. A) 39:1-6.
Bonner et al., J. Antibiot. (1988) 41:1745-1751.
Egner et al., Tetrahedron (Oct. 1997) 53(41):14021-14030.
Goldrick, Am. J. Nurs. (2002) 102:17.
Green, Expert Opin. Ther. Targets (2002) 6:1-19.
Johnson et al., J. Hosp. Infect. (2001 Suppl. A) 49:3-11.
O'Sullivan et al., J. Antibiot. (1988) 41:1740-1744.
Shoji et al., J. Antibiot. (1988) 41:713-718.
Tymiak et al., J. Org. Chem. (1989) 54:1149-1157.
Alker et al., Tetrahedron (1998) 54:6089-6098.
Anderson and McGregor, J Am Chem Soc (1957) 79:6180-6183.
Bacterial Urinary Tract Infections from the Merck Manual, 8 pages, Accessed Jul. 30, 2007.
Barret et al., Tetrahedron Lett (2001) 42(4):703-705.
Belokon et al., Tetrahedron: Asymmetry (2001) 12:481-485.
Blackburn et al., Drug Metabolism and Disposition (1993) 21(4):573-579.
Bull et al., J Chem Soc Perkin Trans (2001) 1:3281-3287.
Cardillo et al., Synlett (1999) 1727-1730.
Cellulitis from the Merck Manual, 3 pages, Accessed Jul. 30, 2007.
Cohen et al., J Am Chem Soc (2004) 124:2534-2543.
Cystic Fibrosis from the Merck Manual, 7 pages, Accessed Jul. 30, 2007.
Dikler et al., J Mass Spectrometry (1997) 32:1337-1349.
Echner et al., Liebigs Ann Chem (1988) 1095-1098.
English Translation of the International Preliminary Report on Patentability for PCT/EP2005/010856, issued on Apr. 24, 2007, 10 pages.
Harada et al., J of Chrom (2001) 932:75-81.
Hingley, retrieved at http://www.fda.gov/FDAC/features/1998/398—alz.html on Jan. 7, 2009, 6 pages.
International Search Report for PCT/EP2005/010857, mailed on Mar. 27, 2006, 4 pages.
International Search Report for PCT/EP2005/011451, mailed on Feb. 27, 2006, 4 pages.
International Search Report for PCT/EP2007/000645, mailed on May 7, 2007, 4 pages.
International Search Report and Written Opinion for PCT/EP2007/003303, dated Jul. 19, 2007, 16 pages.
International Search Report and Written Opinion for PCT/EP2007/003313, dated Jul. 20, 2007, 10 pages.
IUPAC, Nomenclature and Symbolism for Amino Acids and Peptides, Names and Symbols for Derivatives of Named Peptides, Section 3AA-22 (Recommendations 1983-1992).
Jetten et al., Tetrahedron Lett (1991) 32:6025-6028.
Jiang et al., J Am Chem Soc (2003) 125:1877-1887.
Kalvin et al., J Org Chem (1985) 50(13):2259-2263.
Kato et al., J Antibiot (1988) 41:719-725.
Lee et al., Tetrahedron (2001) 57:2139-2145.
Maki et al., Antimicrob Agents and Chemotherapy (2001) 45(6):1823-1827.
Mattingly et al., J Org Chem (1983) 48:3556-3559.
Merget et al., Organomet Chem (2001) 628:183-194.
Merino et al., Tetrahedron: Asymmetry (1998) 9:629-646.
Murakami et al., Tetrahedron (2000) 56(46):9121-9128.
Neises et al., Org Synth (1985) 63:183-187.
Nomenclature and Symbolism for Amino Acids and Peptides (Recommendations 1983) Biochemical Journal (1984) 219:345-373.
Norman et al., J Org Chem (1998) 63(15):5288-5294.
Oliyai et al., Pharm Res (1995) 12(3):323-328.
Palomo et al., Tetrahedron Lett (2001) 42:8955-8957.
Panico et al., eds., A Guide to IUPAC Nomenclature of Organic Compounds, Blackwell Science Ltd., 1993, pp. 1-190 (Recommendations 1993).
Rane et al., Tetrahedron Lett (1993) 34(20):3201-3204.
Rao et al., Tetrahedron Lett (1991) 32:4393-4396.
Schuhmacher et al., J Pharm Sci (2004) 93:816-830.
Seebach et al., Helv Chim Acta (1996) 79:913-941.
Shemyakin et al., Esperienta (1966) 22(8):535-536.
Tenover, Am J Infect Control (2006) 34:S3-S10.
Thornber, Chem Soc Rev (1979) 8(4):563-580.
Translation of the International Preliminary Report on Patentability for PCT/EP2005/011451, mailed Jul. 12, 2007, 8 pages.
Translation of the International Preliminary Report on Patentability for PCT/EP2005/010857, Apr. 24, 2007, 11 pages.
Translation of the International Preliminary Report on Patentability for PCT/EP2007/000645, issued Sep. 9, 2008, 9 pages.
Ulhaq et al., Bioorg Med Chem (1999) 7(9):1787-1796.
Van Hof et al., Biol Chem (2001) 382:597-619.
Vippagunta et al., Adv Drug Delivery Rev (2001) 48:3-26.
Translation of the International Preliminary Report on Patentability, issued Apr. 24, 2007, 5 pages.
Anlauf Sonja
Bruening Michael-Alexander
Brunner Nina
Endermann Rainer
Fuerstner Chantal
Aicuris GmbH & Co. KG
Gupta Anish
Ha Julie
Morrison & Foerster / LLP
LandOfFree
Deoxonadepsipeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Deoxonadepsipeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deoxonadepsipeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4243587